Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$507M |
| 2 |
LPL Financial
LPLA
|
+$446M |
| 3 |
Hewlett Packard
HPE
|
+$425M |
| 4 |
PG&E
PCG
|
+$279M |
| 5 |
Unilever
UL
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$390M |
| 2 |
Lennar Class A
LEN
|
+$368M |
| 3 |
Nice
NICE
|
+$334M |
| 4 |
Ciena
CIEN
|
+$327M |
| 5 |
Philip Morris
PM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.5% |
| 2 | Technology | 17.28% |
| 3 | Healthcare | 11.28% |
| 4 | Industrials | 8.54% |
| 5 | Utilities | 8.44% |
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q4 2025 Portfolio in Review
As of Q4 2025, Barrow, Hanley, Mewhinney & Strauss held 418 positions worth $30B, down 4.4% from $31.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss withdrew a net $2.3B in Q4 2025, closing 51 positions and reducing 118 holdings. Its most notable exit was Las Vegas Sands, an estimated $293M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Barrow, Hanley, Mewhinney & Strauss opened a new position in GE HealthCare worth $534M.
- Barrow, Hanley, Mewhinney & Strauss's largest Q4 2025 buy was GE HealthCare: 6,506,398 shares worth $534M.
- Barrow, Hanley, Mewhinney & Strauss added most to PG&E in Q4 2025, an estimated $279M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q4 2025 reduction was Vertiv, cutting an estimated $390M.
- Barrow, Hanley, Mewhinney & Strauss fully exited Las Vegas Sands in Q4 2025, selling an estimated $293M.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 23% of its $30B portfolio in Q4 2025.
- Barrow, Hanley, Mewhinney & Strauss opened 69 new positions and closed 51 in Q4 2025.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value fell 4.4% quarter-over-quarter to $30B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2025, filed 11 Feb 2026.